Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.
Press releases published on June 30, 2025
IRS Raises 2026 HSA Contribution Limits—More Tax-Free Healthcare Savings Ahead
EIN Presswire
·
June 30, 2025
IRS Raises 2026 HSA Contribution Limits, Promoting Expanded Tax-Free Healthcare Savings Opportunities FORT COLLINS, CO, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Increased contribution caps open the door for Americans to grow more tax-free …
JPLoft Expands Service Portfolio with Custom AI in Healthcare Solutions for Hospitals and Startups
EIN Presswire
·
June 30, 2025
JPLoft delivers AI in healthcare solutions that streamline workflows, personalize patient care, and drive innovation in the digital health space. DENVER, CO, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- As the global healthcare sector continues to …
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
GlobeNewswire
·
June 30, 2025
SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
ProHance Showcases RCM Innovation and Workforce Transformation at HFMA 2025
EIN Presswire
·
June 30, 2025
Demonstrated 33% capacity gains, $100K in savings, and $88K productivity boost—ProHance highlights real-world impact of analytics in healthcare RCM. DENVER, CO, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- ProHance, a new-age workplace analytics …
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
GlobeNewswire
·
June 30, 2025
TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and …
Thought Leadership & Innovation Foundation Releases White Paper Showcasing Model for Non-Profit Collaboration to Improve Outcomes for Chronic Disease Communities
GlobeNewswire
·
June 30, 2025
MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- The Thought Leadership …
Avicanna Announces Results of Annual General Meeting
GlobeNewswire
·
June 30, 2025
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
GlobeNewswire
·
June 30, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), …
Academy Announces Host, Executive Producer and Author Andy Cohen as 2025 FNCE® Closing Keynote Speaker
GlobeNewswire
·
June 30, 2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Food and nutrition experts from around the world will gather in Nashville, Tenn., October 11-14, for the Academy of Nutrition and Dietetics' 2025 Food …
TerrAscend Announces Strategic Exit from Michigan Market
GlobeNewswire
·
June 30, 2025
Net Proceeds from divestitures to pay down Company debt Enables concentrated growth and improved profitability in core markets TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend”) (TSX: TSND, OTCQX: TSNDF), a leading North American …
Aptose Announces Deferral of Interest Payment
GlobeNewswire
·
June 30, 2025
SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 30, 2025
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported today that Pyxis Oncology’s …
PetVivo Reports Fiscal 2025 Results
GlobeNewswire
·
June 30, 2025
MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative medical therapeutics for equines and …
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
GlobeNewswire
·
June 30, 2025
CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider …
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
·
June 30, 2025
Boca Raton, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, (the …
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
June 30, 2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has …
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
GlobeNewswire
·
June 30, 2025
As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all participants currently enrolled is now …
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
GlobeNewswire
·
June 30, 2025
Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both biochemical and symptom control with a well-tolerated safety profile in patients switching treatments and those not previously …
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
GlobeNewswire
·
June 30, 2025
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company …
I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research
GlobeNewswire
·
June 30, 2025
Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab plus chemotherapy ROCKVILLE, MD, June 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech …